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Objective The aim of this article is to describe the incidence and
characteristics of pregnancy-related death in low- and middle-
resource settings, in relation to the availability of key obstetric
resources.
Design This is a secondary analysis of a stepped-wedge cluster
randomised controlled trial.
Setting This trial was undertaken at ten sites across eight low-
and middle-income countries in sub-Saharan Africa, India and
Haiti.
Population Institutional-level consent was obtained and all women
presenting for maternity care were eligible for inclusion.
Methods Pregnancy-related deaths were collected prospectively
from routine data sources and active case searching.
Main outcome measures Pregnancy-related death, place, timing
and age of maternal death, and neonatal outcomes in women with
this outcome.
Results Over 20 months, in 536 233 deliveries there were 998
maternal deaths (18.6/10 000, range 28/10 000–630/10 000). The
leading causes of death were obstetric haemorrhage (36.0%,
n = 359), hypertensive disorders of pregnancy (20.6%, n = 206),
sepsis (14.1%, n = 141) and other (26.5%, n = 264).
Approximately a quarter of deaths occurred prior to delivery
(28.4%, n = 283), 35.7% (n = 356) occurred on the day of
delivery and 35.9% (n = 359) occurred after delivery. Half of
maternal deaths (50.6%; n = 505) occurred in women aged 20–
29 years, 10.3% (n = 103) occurred in women aged under
20 years, 34.5% (n = 344) occurred in women aged 30–39 years
and 4.6% (n = 46) occurred in women aged ≥40 years. There was
no measured association between the availability of key obstetric
resources and the rate of pregnancy-related death.
Conclusions The large variation in the rate of pregnancy-related
death, irrespective of resource availability, emphasises that
inequality and inequity in health care persists.
Keywords Epidemiology, low and middle resource, maternal
mortality.
Tweetable abstract Inequality and inequity in pregnancy-related
death persists globally, irrespective of resource availability.
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In 2017, an estimated 295 000 women died as a result of
pregnancy and childbirth. There are stark inequalities in
the risk of death worldwide, where the lifetime risk of
maternal mortality in sub-Saharan Africa is 1 in 37, com-
pared with 1 in 4800 in Europe and Northern America.1
There are methodological challenges with measuring
maternal death. Many countries with the highest rates of
maternal death lack comprehensive civil registration sys-
tems and accurate reporting, and therefore pose a major
challenge. Classification of the cause of death is also chal-
lenging, especially where the certification of death is not
formalised.2 Even when a civil registration system exists, in
the absence of active case finding, maternal deaths may be
misclassified and the use of diverse sources, including
household surveys, censuses and verbal autopsies, limits
comparisons of maternal mortality worldwide.1 Interna-
tional comparisons are therefore usually based on modelled
estimates.1 For some countries these are given with wide
ranges (e.g. in Sierra Leone, 808–1620/100 000 births),
showing the absence of reliable, prospective data in these
countries.
The leading causes of maternal death worldwide are
haemorrhage (27%), hypertensive disorders of pregnancy
(14%) and sepsis (11%).3 These proportions vary by
region: for example, hypertensive disorders contribute to a
greater proportion of deaths in Latin America and the Car-
ibbean (22.1%), compared with sub-Saharan Africa
(16.0%).3 A review of 14, predominantly small, regional
studies, concluded that the majority of maternal deaths
occur in hospital (from 40% in Vietnam to 92% in South
Africa).4 The proportion varied greatly depending on the
country and the data collection method, where capturing
deaths in the community can be challenging. Data mod-
elled from a variety of sources estimate that globally, a
quarter of deaths occur antepartum (24.6%), slightly over a
quarter occur intrapartum or within 24 hours of delivery
(27.7%), a third occur within 42 days of delivery (35.6%)
and a minority occur later than this.5 The lack of reliable
country-specific data is important in research and policy,
as it is not clear where interventions should be targeted to
have the greatest impact on mortality.
The aim of this article is to describe the accurate inci-
dence (per 10 000 deliveries) and characteristics of preg-
nancy-related death (defined as all deaths that occur in
pregnancy and up to 42 days after delivery, irrespective of
cause6) across ten geographical regions, collected prospec-
tively in eight low- and middle-income countries in rela-
tion to key obstetric resources. The secondary aim is to
describe the effect of novel vital sign device and educa-
tional package on pregnancy-related death.
Methods
This is a secondary analysis of a pragmatic, stepped-wedge
cluster randomised controlled trial of the introduction of
the Community Blood Pressure Monitoring in Rural Africa:
Detection of Underlying Pre-Eclampsia (CRADLE) inter-
vention into routine maternity care in ten regions across
Zimbabwe, Zambia, Sierra Leone, Malawi, Ethiopia,
Uganda, Haiti and India over 20 months, from 1 April
2016 to 30 November 2017 (International Standard Ran-
domised Controlled Trial Number, ISCRTN: 41244132).7,8
The CRADLE intervention consisted of the CRADLE Vital
Sign Alert,7,9 a validated device that accurately measures
blood pressure (BP) and heart rate and calculates the shock
index, displaying the results on a traffic light early warning
system, and a simple education package on how to use the
device and respond to abnormal vital signs.10,11 This inter-
vention was compared with routine maternity care using
local management guidelines.
Each region comprised at least one secondary or tertiary
health facility that provided comprehensive emergency
obstetric care with the main peripheral facilities that refer to
these hospitals. All secondary or tertiary hospitals were urban
or peri-urban, but the geographical regions of peripheral
facilities covered a range of settings, with the mean distance
varying from 3.3 to 74.0 km to the referral centre. Commu-
nity healthcare providers were included, when they were for-
mally involved in routine maternity care provision and
supported at the district level.7 The intervention was deliv-
ered to all healthcare professionals (HCPs) working in gynae-
cology and maternity in the facilities of the region.
Core outcomes
The primary outcome of the trial was a composite outcome
of maternal mortality and morbidity (at least one of
eclampsia, emergency obstetric hysterectomy and maternal
death). In spite of a 9% reduction in the primary outcome
over time, the trial was unable to demonstrate an effect of
the intervention as a result of the unexpected degree of
variation between and within regions. All women that were
recorded as having died at any gestation or up to 42 days
after delivery, from any cause, between 1 April 2016 and 31
November 2017 were eligible for inclusion as a pregnancy-
related death case in this secondary analysis. The denomi-
nator was all deliveries in the trial area in the same period.
For each woman, data were collected on the cause of death,
maternal age, timing and place of pregnancy-related death
(community, peripheral facility or central referral facility).
The number of stillbirths and neonatal deaths up to
28 days was recorded in all women that died. These out-
comes were selected as they are of great clinical impor-
tance; no core outcome set was available.
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Regions were described by the number of deliveries,
number of HCPs working in maternity, the number of
intensive care unit (ICU) beds per 1000 deliveries and the
proportion of facilities where blood transfusion was avail-
able on a monthly basis. Methods of data collection were
discussed and optimised based on the existing resources
available in each region. All data collectors were given
detailed training to ensure the comparability of results.
Outcomes were triangulated across multiple sources
depending on the reliability in each region (including refer-
ral registers, ward registers, patient records, local mortality
and morbidity records, and active case searching) to ensure
data completeness, and all outcomes were checked to avoid
double counting. The systematic reporting of community
cases, for example through household surveys, was not
undertaken. Therefore, community cases are included
where reported, and in these predominantly urban settings,
we consider that most community deaths were made
known to our researchers. All data were entered onto a
standardised electronic central database. Where possible,
cause of death was attributed to the highest-level cause in
keeping with the WHO guidance on cause of death.12
Ethics, consent and patient involvement
Ethical approval was granted by the Biomedical Sciences,
Dentistry, Medicine and Natural and Mathematical
Sciences Research Ethics Subcommittee at King’s College
London (LRS-14/15-1484) and at each study centre (ex-
cluding Haiti, for which Memorandum of Understandings
were created because of the lack of existing process). This
and all local ethical approvals were in place prior to the
start of the study. Institutional-level consent on behalf of
the cluster was obtained. Patients or the public were not
involved in the design, conduct, reporting or dissemination
plans of our research.
Statistical methods and analysis
Statistical analyses were undertaken in STATA 13.1 (Stata-
Corp LLC, College Station, TX, USA). We used logistic
regression on monthly data with standard errors corrected
for clustering by centre ID, and with no fixed effect of cen-
tre.13 Results are reported as odds ratios (ORs) with 95%
confidence intervals. The trial protocol stated that further
details of the individual components of the primary out-
come would be analysed, such as cause and place of death.7
To describe the association between death and resource
availability, pregnancy-related death rates for each centre
and time period (month) were calculated. The correlation
of ICU bed availability (average per 10 000 deliveries),
blood transfusion availability (mean percentage of facilities)
and HCPs (average per 1000 deliveries) with maternal
death by region used linear regression for the log of preg-
nancy-related death rate, with robust standard errors.
Analyses were corrected for clustering by centre with no
fixed effects. Individual patient data were only collected for
known cases.
Results
In this cohort of 536 233 deliveries there were 998 preg-
nancy-related deaths over 20 months. This gives an overall
incidence of 0.19 (18.6/10 000 deliveries); however, the
rates of mortality varied substantially between regions, as
shown in Table 1 (ranging from 2.8/10 000 in Zambia
Centre 1 to 63.0/10 000 in Sierra Leone).
The overall leading causes of mortality were obstetric
haemorrhage (36.0%, n = 359), hypertensive disorders of
pregnancy (20.6%, n = 206), sepsis (14.1%, n = 141) and
other (26.5%, n = 264), with the causes included in ‘other’
each representing individual contributions of less than 4%.
The causes of death categorised as other included anaemia
(3.4%, n = 34), early pregnancy complications (3.0%,
n = 30) and malaria (2.3%, n = 23). The proportions var-
ied between regions, as shown in Table S1 (obstetric haem-
orrhage, ranging from 15.2% in India to 44.5% in Uganda
Centre 1; sepsis, ranging from 0.0% in Haiti to 27.5% in
Zimbabwe; hypertensive disorders of pregnancy, ranging
from 9.9% in Zambia Centre 2 to 68.0% in Haiti). After
planned adjustments for clustering and time trends in each
region, the implementation of the CRADLE intervention
was not associated with any significant change in the rates
of death from any cause, although unexpected variability
between regions and over time meant that we could not
rule out an effect (Table 2).
Half of pregnancy-related deaths (50.6%, n = 505)
occurred in women aged 20–29 years, 10.3% (n = 103)
occurred in women aged under 20 years, 34.5% (n = 344)
occurred in women aged 30–39 years and 4.6% (n = 46)
occurred in women aged ≥40 years. The variation in age at
death between regions is shown in Figure 1 and Table S2.
Slightly over a quarter of deaths occurred prior to delivery
(28.4%, n = 283), with similar proportions occurring on
the day of delivery (35.7%, n = 356) and after delivery
(35.9%; n = 359). Of the deaths that occurred after deliv-
ery, the majority were within the first 7 days after delivery
(24.8%, n = 248), with a further 11.1% (n = 111) occur-
ring more than 7 days after delivery (Figure 2; Table S2).
Across all study regions, only 1.8% (n = 18) of deaths were
reported to have occurred in the community (Table S3).
Overall, 715 women died after delivery, of which 46.9%
(n = 335) had been delivered by caesarean section (ranging
from 38.3% in Uganda Centre 2 to 65.2% in Haiti;
Table S4). Nearly half of women who died after delivery
suffered a stillbirth or a neonatal death (42.5%; n = 310),
which ranged from 29.2% in Malawi to 48.5% in Sierra
Leone (Table S4).
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Overall, the number of HCPs working in maternity ser-
vices was 282 per 1000 deliveries. This ranged from 125 per
1000 deliveries in Zambia Centre 1 to 374.3 per 1000 deliv-
eries in Sierra Leone (Table S5). There was no detectable
association between the total number of HCPs available
and the rates of pregnancy-related death in each region
(OR 1.00, 95% CI 1.00–1.01). Two regions, Sierra Leone
and Uganda Centre 2, did not have any ICU facility
Table 1. Maternal death per 10 000 deliveries, by region and by intervention
Region Overall Pre-intervention Post-intervention

























































































































































*Analysis did not converge.
**Eclampsia, pre-eclampsia or stroke.
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available. The number of ICU beds per 1000 deliveries in
the other regions ranged from 0.8 per 1000 deliveries in
Haiti to 24.5 per 1000 deliveries in India. There was also
no detectable association between the number of ICU beds
per 1000 deliveries and the rates of pregnancy-related death
in each region (0 beds, OR 0.69, 95% CI 0.18–2.63; 1–5
beds/1000 deliveries, OR 132, 95% CI 0.49–3.69; 6–10 beds
per 1000 deliveries, OR 0.65, 95% CI 0.34–1.23). On aver-
age, blood transfusion was available in 25.1% of facilities
(ranging from 6.5% in Zambia Centre 2 to 75% in
Malawi). There was no evidence of a significant association
between the overall availability of blood transfusion and
the rate of pregnancy-related death in that region (OR
1.00, 95% CI 0.98–1.03; Table S5).
Discussion
Main findings
Overall, we have found the pregnancy-related death rate to
be 18.6/10 000 deliveries, with large variation across individ-
ual regions. The leading causes of death were obstetric
haemorrhage (36.0%), hypertensive disorders of pregnancy
(20.6%), sepsis (14.1%) and other (26.5%). The majority of
deaths across all regions occurred in healthcare facilities
(98.1%), after delivery (35.9%) and in women aged 20–
29 years (50.6%). Overall, the implementation of the CRA-
DLE intervention was not associated with any significant
change in the rates of pregnancy-related death, but the effect
varied across individual sites. We did not identify any signifi-
cant association between the measured availability of key
obstetric resources and pregnancy-related death rates.
Strengths and limitations
The strengths of this study are the rigorous prospective
data collection methods, verified from multiple sources,
and the inclusion of multiple settings. Existing prospective
data sets are frequently small and are measured at hospital
level, with limited information on the place or timing of
death. The data presented here improve the accuracy of
incidence estimates by reporting these factors and including
cases across the health system, including cases from pri-
mary healthcare facilities and community cases.
Figure 1. Maternal age at death per 10 000 deliveries, by region and overall.
Figure 2. Timing of maternal death per 10 000 deliveries, by region and overall.
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The data were collected during a randomised controlled
trial and therefore include measurements before and after
the introduction of the intervention, with the included
regions selected for research purposes. Although the geo-
graphical settings varied, it is a limitation of this study that
the majority were urban or peri-urban and may not be rep-
resentative of nationwide mortality rates. The incidences of
mortality reported in this study are lower than recent mod-
elled estimates in all countries except India.1 This may be
representative of the urban settings,4 or could indicate the
underreporting of community cases, as systematic commu-
nity collection was beyond the capacity of this study. These
factors may also explain the lower proportion of deaths
reported in the community compared with the literature.4
As a result of the study size, it was not feasible to collect
demographic data in the denominator group, and therefore
the proportion of deaths in different age groups cannot be
presented at population level. The cause of death was based
on data reported by attending clinicians and other docu-
mented or observed factors, as determined by our trained
research team. Attributing cause of death was challenging
in all regions, because of complex and late presentations to
hospital and poor documentation; however, we have
demonstrated that the collection of maternal mortality data
and entry onto a standardised electronic database is feasible
across ten sites with varying infrastructure. It is a strength
that this paper reports resource availability, but the daily
fluctuations in resource availability remain unknown. The
number of HCPs working in maternity facilities was higher
than anticipated.14 This may be linked to the inclusion of
untrained support staff or employed staff not regularly
working, and therefore might not be a true reflection of
the coverage of trained staff providing high-quality care.
Interpretation (in light of other evidence)
In the post-Millennium Development Goal era, the global
health focus is on not just reducing mortality but also
reducing morbidity.15 Yet in this study more than 20-fold
variation in mortality was observed between regions, sug-
gesting that the focus on maternal mortality globally should
not be lost.
In this study, the proportion of deaths from hypertensive
disorders of pregnancy was higher than previously cited
(20.6% reported compared with 14.0% worldwide and
16.0% in sub-Saharan Africa, where 94.2% of the deaths in
our study occurred). This may relate to improved case
acquisition after the introduction of the intervention,
resulting in the increased reporting of deaths from hyper-
tensive disorder of pregnancy, or the necessity for the
research team to record a single leading cause of death
(e.g. hypertensive disorder of pregnancy instead of dissemi-
nated intravascular coagulation). This highlights the chal-
lenges of recording maternal mortality worldwide, despite
guidance from the WHO.12 Even physician-certified death
may be complex because of limited diagnostic services and
late presentation at the facility. Continued training and
development of local policy in registering maternal deaths
is required to ensure the accuracy and comparability of the
data, which in turn is vital to inform practice.
Our data suggest that the vast majority of deaths
occurred in hospital, despite relatively good availability of
resources, probably through a combination of women who
arrive too unwell to benefit from emergency care, women
with complications who could have been treated with
timely effective interventions and women who develop seri-
ous complications whilst in hospital. Deaths from women
arriving seriously unwell indicate that delays were experi-
enced in deciding to seek and reach care, suggesting a con-
tinued need to focus on health system and community
factors, such as referral pathways and transport. Impor-
tantly, high-quality care within health facilities is required
to reduce all causes of maternal deaths.16 Evidence from
low-income countries suggests that increasing the rate of
deliveries that occur in facilities does not necessarily equate
to improved maternal or neonatal outcomes, because of
the poor quality of care, which is estimated to contribute
to half of all maternal deaths.17 Policymakers must there-
fore address both coverage and service quality to achieve
improvements in maternal health.
In keeping with the literature,4 over a third of women
died on the day of delivery (35.7%) and the majority died
from obstetric haemorrhage (36.0%). The WHO makes 32
evidence-based recommendations for the prevention and
treatment of postpartum haemorrhage.18 Therefore, HCPs
and policymakers have the opportunity to target interven-
tions to this high-risk period, focusing on access and the
timely delivery of proven, effective interventions.
In this study, the majority of deaths occurred in women
aged 20–29 years, probably reflecting the greatest propor-
tion of births occurring in this group as opposed to a
greater relative risk. Nearly half of maternal deaths occurred
in women who delivered by caesarean section (45.9%). This
is higher than a recent systematic review, in which a quarter
of all women who died in low- and middle-income coun-
tries (LMICs) had undergone caesarean section (23.8%,
95% CI 21.0–26.7),19 possibly reflecting the urban setting of
our study. The elevated proportion of caesarean sections in
this group is likely to indicate severe morbidity necessitating
the rapid delivery of the baby; however, it may also add to
the literature that mortality risk is disproportionately high
following caesarean section in LMICs.19 This is likely to be
of increasing future importance as rates of caesarean deliv-
ery increase globally.20 HCPs and policymakers need to
address access to surgery and navigate the challenging bal-
ance of under- and overuse of delivery by caesarean sec-
tion,21 alongside appropriate decision making for caesarean
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sections, such as adequate training and supervision to man-
age labour and its complications.
We hypothesised that the introduction of the interven-
tion would improve the efficiency and capacity of HCPs to
identify, escalate and manage pregnancy complications by
increasing the availability of equipment and improving
understanding through training and the traffic light early
warning system. Although this study has shown no effect
of the CRADLE intervention on maternal death, there were
trends towards reduced mortality overall and reduced mor-
tality from haemorrhage, sepsis and pregnancy-associated
hypertension. Given that this study was not powered to
detect differences in individual components of the primary
outcome, and had unexpected variation across regions, this
warrants further research.
The effect of the intervention differed across regions. It
is possible that differing provision of community care,
acceptability and infrastructure to facilitate timely referral,
and capacity of facilities to provide high-quality, timely
care in response to deteriorating vital signs, may all con-
tribute to these differences. Interpretation is challenging,
however, as individual sites may be influenced by changes
in mortality rates over time, irrespective of the introduc-
tion of the intervention, and therefore we considered that
this analysis may be misleading.
Conclusion
In conclusion, this analysis provides accurate contempora-
neous estimates of incidence of pregnancy-related death
from a large prospective data set across eight low- and
middle-resource settings. These data highlight that mortal-
ity (for the woman and the baby) remains high, with preg-
nancy and the perinatal period needing continued
prioritisation in research and policy. The high proportion
of mortality in facility settings indicates that the quality of
care and delivery of effective interventions, in addition to
timely access to care, is vital. Significant variation across
regions and countries, unrelated to staffing levels and inter-
ventions, requires an evaluation to define the components
that need to be focused on in order to reduce mortality.
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